Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @AccentureLifSci
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AccentureLifSci
-
Prikvačeni tweet
Calling global
#HealthTech & life sciences#Startups! Apply now for Accenture Life Sciences#HealthTechChallenge https://accntu.re/37zRGPj pic.twitter.com/sScCqnTn9U
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
40% of companies have not deployed digital in the lab. Our new report maps out the journey to turn oceans of siloed information into innovative therapies: https://accntu.re/36ouxOn pic.twitter.com/CHUW1Czc4i
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AccentureLifeScience proslijedio/la je Tweet
We’re proud to achieve SAP Model Company certifications for faster implementation & time-to-value with
@SAP industry solutions: https://accntu.re/36u75PB#S4HANApic.twitter.com/4ffJCN9rLB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Who will manage and capitalize on the tsunami of CGT development assets? We see 6 types of emerging businesses. https://accntu.re/37qLI2P pic.twitter.com/eUOIORW5MY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Attention
#HealthTech#Startups! Our life sciences#HealthTechChallenge is accepting applications thru February 29, 2020. https://accntu.re/2sSPbIw pic.twitter.com/RPeXVmrB4z
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
With a cloud-based platform at the heart of its business, Merck KGaA is improving fulfillment to ensure patients have the medicine they need: https://accntu.re/2uqgv1p pic.twitter.com/vPvx3ePHsi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are working with Biopharma Chief Scientific Officers and Research & Development leaders to fix productivity issues and develop new drugs radically faster and more effectively. Find out more: https://accntu.re/2NKQv7t pic.twitter.com/pmQivTI9Iw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Be a leader in the digital world—and improve the lives of people everywhere—with these 5 key enablers: https://accntu.re/36pU5dU pic.twitter.com/PQsTXGXq7N
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New Science will account for 54% of sales by 2022. Is your lab ready for the latest wave of R&D technology? https://accntu.re/37qCL9P pic.twitter.com/nnGkzzfX0X
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
See how Merck KGaA’s new digital backbone—a more agile and nimble ERP platform—is helping them get medicine to patients faster: https://accntu.re/30OAPp8 pic.twitter.com/U7IBZkt7n8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How can cancer care teams make better treatment decisions faster? Learn how Roche’s NAVIFY® Tumor Board digital data integration solution is transforming prep for tumor board meetings. https://accntu.re/35BdFDt pic.twitter.com/oPsggmtrd6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
6 out of ten
#biopharma marketing execs say their marketing organization isn’t ready for Artificial Intelligence. See how to make AI happen now. Learn more. https://accntu.re/3aCAWZA pic.twitter.com/8KSytJrTej
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How can life sciences companies apply truly innovative clinical operations that consist of a cross-section of talented people, with the right clinical data science skills embedded into a well-functioning clinical governance model? https://accntu.re/3anouwF pic.twitter.com/YiQ0E4dgfJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Are you ready to unlearn and relearn the
#drugdelivery value chain to bring transformative therapies to patients? Learn more: https://accntu.re/2Rvnj5F pic.twitter.com/6sUQ3KHICW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Most CEOs say they have the right IT systems, but are failing to get full value from them. Why? We'll share more next week at
#WEF20: https://accntu.re/2TywpBk#AccentureAtDavospic.twitter.com/cBSWarHggp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Four days. 1,500 leaders. One mission to drive positive change and improve the state of the world. https://accntu.re/2thwNJO
#AccentureAtDavos#WEF20pic.twitter.com/jNqBVOC11tHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Over half of
#biopharma marketing execs (57%) have access to data but are struggling to make better decisions with it. It’s time to change the dynamic. Learn more. https://accntu.re/2SI0BcN pic.twitter.com/bPMZZm2Seu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Accenture congratulates Dr. Sandra Horning
@genetech,@Roche as HBA’s Woman of the Year and is proud to host this year’s meeting. It's exciting to see orgs such as HBA supporting companies that recognize the power of the diversity. https://accntu.re/38avg75#HBAWOTY20#HBAimpactpic.twitter.com/vTTc2NRPB5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Find out how Roche’s data platform NAVIFY® Tumor Board is helping specialists spend less time preparing for meetings—and more time discussing patients. https://accntu.re/35Am7mv pic.twitter.com/RVvzvy42Gm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer care teams need patient information from many sources to make the best decisions. Find out how Roche’s NAVIFY® Tumor Board is helping tumor boards do it faster and better. https://accntu.re/35DAgiK pic.twitter.com/PjZdONjepi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.